doi: 10.1111/j.1469-7610.2008.01913.x 154 MercerREWevrickR
REFERENCES: Kevin Kargman, Semaglutide and Blood Clots: What You Need to Know for Safety and Health, May 29, 2024 Yaqin Zhang, Ruofei Chen, Yangyang Jia, Mingwei Chen, Zongwen Shuai, Effects of Exenatide on Coagulation and Platelet Aggregation in Patients with Type 2 Diabetes, Drug Des Devel Ther 2021 Jul 12;15:30273040 " Ingram, I., GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots, MedPage TodayDecember 8, 2024, ABSTRACT: Patell R "Glucagon-like peptide 1 receptor agonists reduce the risk of venous thromboembolism in patients with diabetes irrespective of obesity: a propensity score-matched multicenter database analysis" ASH 2024
For the most up-to-date information on NHS access, eligibility criteria, and service availability, patients are encouraged to visit www.nice.org.uk and www.nhs.uk
As a peptide-based prescription drug, semaglutide requires specific storage conditions to maintain its structural integrity and therapeutic efficacy
Summary of Product Characteristics (Invokana)